Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication
Malignant pleural mesothelioma is a fast-spreading cancer tied to asbestos. Sadly, patients on standard treatments survive just 12–18 months. However, recent studies show better outcomes for some, especially women. They receive ePD surgery, part of a combined treatment. Now, a new article examines mesothelioma patient outcomes. It looks at the factors impacting survival and the benefits of specific treatments. Understanding Pleural Mesothelioma and the Pleural Space Pleural mesothelioma is a cancer in the pleura, the thin membrane around the lungs and chest. It’s mainly caused by asbestos exposure, from work or the environment. This cancer affects the pleural space, crucial for lung movement during breathing. A tumor or pleural effusion, excess fluid, can harm breathing and worsen mesothelioma symptoms. Clinical…